The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Open accessAbstract
Our understanding of Alzheimer's disease pathogenesis is currently limited by difficulties in obtaining live neurons from patients and the inability to model the sporadic form of the disease. It may be possible to overcome these challenges by reprogramming primary cells from patients into induced pluripotent stem cells (iPSCs). Here we reprogrammed primary fibroblasts from two patients with familial Alzheimer's disease, both caused by a duplication of the amyloid-β precursor protein gene (APP; termed APP(Dp)), two with sporadic Alzheimer's disease (termed sAD1, sAD2) and two non-demented control individuals into iPSC lines. Neurons from differentiated cultures were purified with fluorescence-activated cell sorting and characterized. Purified cultures contained more than 90% neurons, clustered with fetal brain messenger RNA samples by microarray criteria, and could form functional synaptic contacts. Virtually all cells exhibited normal electrophysiological activity. Relative to controls, iPSC-derived, purified neurons from the two APP(Dp) patients and patient sAD2 exhibited significantly higher levels of the pathological markers amyloid-β(1-40), phospho-tau(Thr 231) and active glycogen synthase kinase-3β (aGSK-3β). Neurons from APP(Dp) and sAD2 patients also accumulated large RAB5-positive early endosomes compared to controls. Treatment of purified neurons with β-secretase inhibitors, but not γ-secretase inhibitors, caused significant reductions in phospho-Tau(Thr 231) and aGSK-3β levels. These results suggest a direct relationship between APP proteolytic processing, but not amyloid-β, in GSK-3β activation and tau phosphorylation in human neurons. Additionally, we observed that neurons with the genome of one sAD patient exhibited the phenotypes seen in familial Alzheimer's disease samples. More generally, we demonstrate that iPSC technology can be used to observe phenotypes relevant to Alzheimer's disease, even though it can take decades for overt disease to manifest in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“iPSC-derived neurons from individuals with AD exhibit increased production of Aβ42, active GSK-3β, phosphorylated tau, endosomal abnormalities, and oxidative stress (12–17)”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but late-stage neuropathological features, such as formation of insoluble tau and neurodegeneration have not been reported.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulation of pTau in FAD neurons can be reversed by inhibition of β-secretase, the enzyme that converts APP to β-CTF indicating a direct relationship between APP processing and Tau (Israel et al., 2012, Moore et al., 2015).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In iPSC-derived neurons from both FAD- and SAD-patients, pTau aberrantly accumulates at early time points (Choi et al., 2014, Israel et al., 2012, Moore et al., 2015, Muratore et al., 2014, Ochalek et al., 2017, Shi et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, neuronal endosomal swelling has been classed as an early hallmark of Alzheimer's disease indicative of a perturbation in endosomal cargo sorting [8,9,56].”
From Global identification of neuronal and astrocytic integral membrane proteins that require Retromer for their endosomal recycling (2026) · cites this paper as [56]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, inhibition of γ-secretase (to prevent generation of Aβ from β-CTF) did not reduce pTau, indicating that the effect of APP processing on pTau in early AD neurons is not solely mediated by extracellular Aβ (Israel et al., 2012, Moore et al., 2015).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“pThr231Tau accumulates in APP duplication (APPdp) iPSC-derived FAD neurons (Israel et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
In the citing paper
“Several studies related to neurological disease successfully reverted a disease-associated cellular phenotype in patient-derived cells by correcting the disease-associated mutation, for example in the MAPT gene106,107.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [106]
In the citing paper
“Multiple groups have characterized iPSC lines from donor cells from FAD and sAD patients, which show increased production of Aβ, particularly Aβ42, and tau hyperphosphorylation in comparison to iPSCs derived from age-matched non-demented controls [66, 82, 101, 175].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [66]
In the citing paper
“Some iPSC lines also have evidence of additional AD-associated pathology such as increased activation of GSK3β [66], increased number of large endosomes [66], and accumulation of intraneuronal Aβ oligomers [82].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Liang, Q., Fujita, R., Yamashita, T., Angulo, S. L., Rhinn, H., Rhee, D. B., Doege, C. A., Chau, L., Aubry, L., Vanti, W. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.007 · Cited by 231
RetractedInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798
Cited by
Sorted by citations
Items 901–1,000 of 1,002
Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer’s disease
Csöbönyeiová, M., Polák, Š., & Danišovič, Ľ. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0054 · Cited by 5
Stem Cell Technology for (Epi)genetic Brain Disorders
Riemens, R. J. M., Soares, E. S., Esteller, M., & Delgado‐Morales, R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_23 · Cited by 6
The Amyloid Precursor Protein: More than Just Amyloid- Beta
Jevtic, S. D., & Provias, J. (2019) · Journal of Neurology and Experimental Neuroscience · doi:10.17756/jnen.2019-045 · Cited by 5
Translational potential of hiPSCs in predictive modeling of heart development and disease
Mansfield, C., Zhao, M., & Basu, M. (2022) · Birth Defects Research · doi:10.1002/bdr2.1999 · Cited by 6
Moazamiyanfar, R., Halabian, R., Ghollasi, M., Poormoghadam, D., Entezari, M., & Enderami, S. E. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03584-2 · Cited by 5
Harasta, A. E., & Ittner, L. M. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_1 · Cited by 5
Casamassa, A., Ferrari, D., Gelati, M., Carella, M., Vescovi, A. L., & Rosati, J. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051860 · Cited by 5
Induced pluripotent stem cells: Landscape for studying and treating hereditary hearing loss
Peng, T., Dong, Y., Zhu, G., & Xie, D. (2014) · Journal of Otology · doi:10.1016/j.joto.2015.02.001 · Cited by 5
The Cellular Memory Disc of Reprogrammed Cells
Anjamrooz, S. H. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9429-4 · Cited by 5
Improving the physiological realism of experimental models
Vinnakota, K. C., Cha, C. Y., Rorsman, P., Balaban, R. S., Gerche, A. L., Wade‐Martins, R., Beard, D. A., & Jeneson, J. A. L. (2016) · Interface Focus · doi:10.1098/rsfs.2015.0076 · Cited by 5
The Advent of the Golden Era of Animal Alternatives
Butzke, D., Grune, B., Kugler, J., Oelgeschläger, M., Seiler, A. E. M., Sittner, D., Liebsch, M., & Luch, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00003-8 · Cited by 7
Paredes‐Redondo, A., & Lin, Y. (2019) · Wiley eBooks · doi:10.1002/9780470015902.a0028371 · Cited by 5
APP β-CTF triggers cell-autonomous synaptic toxicity independent of AβPreprint
Luo, M., Zhou, J., Sun, C., Chen, W., Fu, C., Si, C., Zhang, Y., Geng, Y., & Chen, Y. (2024) · eLife · doi:10.7554/elife.100968 · Cited by 5
Direct conversion of fibroblast into neurons for Alzheimer's disease research: a systematic review
Sattarov, R., Toresson, H., Orbjörn, C., & Mattsson-Carlgren, N. (2023) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230119 · Cited by 4
Cui, A., Patel, R., Bosco, P., Akcan, U., Richters, E., Delgado, P. B., Agalliu, D., & Sproul, A. A. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323397 · Cited by 12
Application of Human Stem Cells to Model Genetic Sensorineural Hearing Loss and Meniere Disease
Lamolda, M., Frejo, L., Gallego‐Martinez, A., & Lopez-Escamez, J. A. (2023) · Cells · doi:10.3390/cells12070988 · Cited by 4
Bibliometric analysis of cerebral organoids and diseases in the last 10 years
Luo, B., Liu, K., & Fan, J. (2023) · Ibrain · doi:10.1002/ibra.12139 · Cited by 5
Peng, K. Y., Liemisa, B., Pasato, J., D’Acunzo, P., Pawlik, M., Heguy, A., Penikalapati, S. C., Labuza, A., Pidikiti, H., Alldred, M. J., et al. (2024) · Traffic · doi:10.1111/tra.12937 · Cited by 4
Modeling Alzheimer's disease using cerebral organoids: Current challenges and prospects
Abijo, A. Z., Olatunji, S., Adelodun, S. T., Asamu, M. O., & Omeiza, N. A. (2024) · Brain Organoid and Systems Neuroscience Journal · doi:10.1016/j.bosn.2024.09.001 · Cited by 6
Human induced pluripotent stem cell models for Alzheimer’s disease research: a bibliometric analysis
Sun, Y., Liu, Z., Zhang, Z., Kang, Y., Wang, X., Zhang, Y., Liu, Y., & Zhao, P. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1548701 · Cited by 4
Tian, J., Du, E. Y., Jia, K., Wang, T., Guo, L., Zigman, J. M., & Du, H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-231002 · Cited by 6
In Vitro Modeling of Complex Neurological Diseases
Soldner, F., & Jaenisch, R. (2017) · Research and perspectives in neurosciences · doi:10.1007/978-3-319-60192-2_1 · Cited by 5
Shim, Y. J., Shin, M. K., Jung, J., Koo, B., & Jang, W. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.996698 · Cited by 5
Nodule Detection in Postero Anterior Chest Radiographs
Campadelli, P., & Casiraghi, E. (2004) · Lecture notes in computer science · doi:10.1007/978-3-540-30136-3_132 · Cited by 4
Mirza, Z., Pillai, V. G., & Zhong, W.-Z. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034221 · Cited by 4
Li, R., Bai, Y., Liu, T., Wang, X., & Wu, Q. (2013) · Protein & Cell · doi:10.1007/s13238-013-2089-y · Cited by 4
Liao, F., & Holtzman, D. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2802 · Cited by 4
Garber, K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2977 · Cited by 4
Holloway, K., Neherin, K., Song, Y., Sato, K., Houston, A., Chen, F., Li, D., & Zhang, H. (2025) · Aging Cell · doi:10.1111/acel.14472 · Cited by 3
Mehrabadi, S. (2025) · Current Aging Science · doi:10.2174/0118746098334856250106055739 · Cited by 3
Flamier, A., Katbe, A., Serhani, D., Hamam, R., Hogan, R., Tavares, E., Héon, E., Hanna, R., & Bernier, G. (2025) · Development · doi:10.1242/dev.204910 · Cited by 3
Choi, D.-K., Kim, Y.-K., HoonYu, J., Min, S., & Park, S.-W. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.020 · Cited by 3
Rimal, S., Li, W., Khaket, T. P., Li, Y., Tantray, I., Li, Y., Bhurtel, S., Grinberg, L. T., Spina, S., Cobos, I., et al. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2024.07 · Cited by 3
Wang, Y., Wang, Z., Wang, L., Sun, Y., Song, H., Cheng, X., He, X., Gao, Z., & Sun, Y. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70027 · Cited by 4
Targeting RPSA to modulate endosomal trafficking and amyloidogenesis in genetic Alzheimer's disease
Limone, A., Napoli, C., Napolitano, F., Imbò, B., Minopoli, G., Bagnoli, S., Izzo, A., Paladino, S., Nacmias, B., Matteis, M. A. D., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167753 · Cited by 3
Saguer, I. L., Gabriele, R. M. C., Bradshaw, T. Y., Leckey, C. A., Belder, C. R. S., Chávez‐Gutiérrez, L., de Silva, R., Fox, N. C., Wray, S., Oxtoby, N. P., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag105 · Cited by 3
High-Throughput Peptide Screening on a Bimodal Imprinting Chip Through MS-SPRi Integration
Wang, W., Fang, Q., & Hu, Z. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3037-1_9 · Cited by 3
Induced pluripotent stem cell technology: venturing into the second decade
Shi, Y., Inoue, H., Takahashi, J. B., & Yamanaka, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00095-2 · Cited by 4
iPSC for modeling of metabolic and neurodegenerative disorders
Valadez-Barba, V., Cota-Coronado, A., Barragán-Álvarez, C. P., Padilla‐Camberos, E., & Diaz-Martinez, N. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823882-0.00007-2 · Cited by 3
Xu, Y., Wang, S., & Zhu, P. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220426114050 · Cited by 3
Mitevska, A., Santacruz, C., Martin, E. J., Jones, I. E., Ghiacy, A., Dixon, S., Mostafazadeh, N., Peng, Z., Kiskinis, E., & Finan, J. D. (2023) · Neurotrauma Reports · doi:10.1089/neur.2023.0060 · Cited by 3
Kshirsagar, S., Islam, M. A., Reddy, A. P., & Reddy, P. H. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241310716 · Cited by 3
Human Pluripotent and Multipotent Stem Cells as Tools for Modeling Neurodegeneration
Mertens, J., Koch, P., & Brüstle, O. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-36648-2_6 · Cited by 3
Approaches to characterize the transcriptional trajectory of human myogenesis
Lim, H., Choi, I. Y., Hyun, S., Kim, H., & Lee, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03782-1 · Cited by 3
Human Pluripotent Stem Cells Modeling Neurodegenerative Diseases
Nat, R., Eigentler, A., & Dechant, G. (2013) · InTech eBooks · doi:10.5772/55772 · Cited by 3
Selfridge, A., Hyun, N., Chiang, C., Reyna, S. M., Weissmiller, A. M., Shi, L. Z., Preece, D., Mobley, W. C., & Berns, M. W. (2015) · Neurophotonics · doi:10.1117/1.nph.2.1.015006 · Cited by 3
Self-citationSantiago-Lopez, A. J., Hovell, C. M., Lee, H., & Kim, Y. (2015) · Biosystems & biorobotics · doi:10.1007/978-3-319-21813-7_13 · Cited by 3
Role of Innate Immune Signaling in Nuclear Reprogramming
Meng, S., Chanda, P. K., & Cooke, J. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-27583-3_9 · Cited by 3
Shirotani, K., Asai, M., & Iwata, N. (2017) · The Journal of Biochemistry · doi:10.1093/jb/mvx015 · Cited by 3
Cubillo, E. J., Ngo, S. M., Juarez, A., Gagan, J., Lopez, G. D., & Stout, D. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2017.3.191 · Cited by 3
Neurodegenerative Diseases and Axonal Transport
Goldstein, L. S. B., & Das, U. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00012-2 · Cited by 3
Self-citationLive-Cell Imaging of Single Neurotrophin Receptor Molecules on Human Neurons in Alzheimer’s Disease
Barabás, K., Kobolák, J., Godó, S., Ernszt, D., Kecskés, M., Varga, C., Kardos, J., Jánosi, T. Z., Fujiwara, T. K., Kusumi, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413260 · Cited by 3
Namchaiw, P., Bunreangsri, P., Eiamcharoen, P., Eiamboonsert, S., & Poo-arporn, R. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273458 · Cited by 3
Rao, M. S. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400127.pub2 · Cited by 3
Preservation of an Aging-Associated Mitochondrial Signature in Advanced Human Neuronal ModelsPreprint
Varghese, N., Szabo, L., Cader, M. Z., Lejri, I., Grimm, A., & Eckert, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.28.587193 · Cited by 3
APP β-CTF triggers cell-autonomous synaptic toxicity independent of AβPreprint
Luo, M., Zhou, J., Sun, C., Chen, W., Fu, C., Si, C., Zhang, Y., Geng, Y., & Chen, Y. (2024) · eLife · doi:10.7554/elife.100968.1 · Cited by 3
Experimental Models of Alzheimer’s Disease
Ercan, M. (2024) · doi:10.69860/nobel.9786053359166.7 · Cited by 3
Trisomy 21 Impairs Synchronized Activity in Human Down Syndrome Cortical Excitatory Neuron NetworksPreprint
Peter, M., Real, R., Strano, A., Robinson, H. P. C., Smith, M. A., Barnes, S. J., Dutta, T., Paola, V. D., & Livesey, F. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.27.630530 · Cited by 2
APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ
Luo, M., Zhou, J., Sun, C., Chen, W., Fu, C., Si, C., Zhang, Y., Geng, Y., & Chen, Y. (2024) · eLife · doi:10.7554/elife.100968.3 · Cited by 7
Curcumin Delivery in Regenerative Medicine for Alzheimer’s Disease
Jafarisavari, Z., Hasanzadeh, E., Tayebi, L., & Asadpour, S. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00482-1 · Cited by 2
Advancements in differentiation of induced pluripotent stem cells into specialized neuronal subtypes
Setsu, S., Okano, H., & Morimoto, S. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00630 · Cited by 2
Amyloid‐β Seeds in Alzheimer's Disease: Research Challenges and Implications
Beschörner, N., Xu, Y., Jucker, M., & Ruiz‐Riquelme, A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70267 · Cited by 2
Neherin, K., Holloway, K., Song, Y., Houston, A., Chen, F., Ding, L., & Zhang, H. (2026) · Advanced Biology · doi:10.1002/adbi.202500468 · Cited by 2
Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks
Mazzachi, P., McDonald, E., Greenberg, Z., Puerta, A. N., Tran, J., Silva, M. I. D., Christensen, C., Adams, R., Loskarn, S., Beard, H., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71112-9 · Cited by 4
Self-citationYuan, S., Essepian, N., Roberts, R., Sherman, E., Gniadzik, W. M., Wang, Q., Erisir, A., & Jiang, L. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03018-1 · Cited by 3
Self-citationHuang, J., Wang, Y.-B., Wu, J., Qian, P.-J., Shao, J., Cao, D.-D., Liu, Y., & Luo, Z. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.037 · Cited by 2
Using iPSC models to examine neuron–glia interactions in neurodegenerative diseases
Lopez, D. M., Keavey, L., & Bowles, K. R. (2026) · Bioscience Reports · doi:10.1042/bsr20250131 · Cited by 2
Translating Alzheimer’s disease proteomics into drug discovery opportunities
Drummond, E., Werry, E. L., Kavanagh, T., Genoud, S., Cho, A., Chen, S., Du, J., Hibbs, D. E., & Kassiou, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00035-y · Cited by 2
Tau-induced mitochondrial reverse electron transport drives neurodegeneration
Li, W., Rimal, S., Bhurtel, S., Yeung, L., Lu, B. G., Grinberg, L. T., Spina, S., Cobos, I., Seeley, W. W., Guo, S., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.07.012 · Cited by 2
Ferraiuolo, L., Meyer, K., & Kaspar, B. K. (2013) · InTech eBooks · doi:10.5772/56487 · Cited by 3
Modeling and Therapeutic Strategies of Pluripotent Stem Cells for Alzheimer’s Disease
Gu, H. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000e115 · Cited by 2
CIRM tools and technologies: Breaking bottlenecks to the development of stem cell therapies
Collins, L. R., & Shepard, K. A. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0055 · Cited by 2
Alzheimer Hastalığı’nda In Vivo ve In Vitro Modeller
Aru, B., DEVELİOĞLU, A., Gürel, G., & Demirel, G. Y. (2023) · Türkiye Sağlık Enstitüleri Başkanlığı Dergisi · doi:10.54537/tusebdergisi.1213712 · Cited by 3
Tissue-Engineered Three-Dimensional Platforms for Disease Modeling and Therapeutic Development
Wheeler, E. E., & Leach, J. K. (2024) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2024.0212 · Cited by 3
Alzheimer’s Disease from Modeling to Mechanism Research
Sun, X., & Zhang, W. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69188-1_7 · Cited by 2
Chun, M. Y., Jung, S., Choe, J., Lee, S., Kim, H., Son, H. J., Choi, Y., Cho, M., Kim, B., Jang, H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70660 · Cited by 2
The Amyloid β Precursor Protein and Cognitive Function in Alzheimer’s Disease
Marr, R. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00004-8 · Cited by 2
Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases
Kumar, S., Narayanan, K., Mishra, S., Padmanabhan, P., Radda, G. K., & Gulyás, B. Z. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1232-4 · Cited by 2
Neural tissue microphysiological systems in the era of patient-derived pluripotent stem cells
Mungenast, A. E., Aron, R., White, J. D., Tardiff, D. F., & Raja, W. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00009-8 · Cited by 2
Liu, S., Zhao, Y., Su, X., Zhou, C., Yang, P., Lin, Q., Li, S., Tan, H., Wang, Q., Wang, C., et al. (2020) · Stem Cells International · doi:10.1155/2020/8897494 · Cited by 2
Autophagic processes in early- and late-onset Alzheimer's disease
Xie, C., Aman, Y., Frank, J., Lagartos-Donate, M. J., Gudmundsrud, R., Čechová, K., Shi, L., Vyhnálek, M., & Fang, E. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822003-0.00012-7 · Cited by 2
Neural Cell Fate Determination
Moore, S., & Livesey, F. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405945-0.00016-8 · Cited by 3
Stem cells slow cognitive decline in Alzheimer's disease via neurotrophin action
Mulvey, R. (2014) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzu013 · Cited by 2
Modeling Parkinson Disease with Human Induced Pluripotent Stem Cells
Lü, J. (2014) · Cloning & Transgenesis · doi:10.4172/2168-9849.1000e113 · Cited by 2
Asai, M., Shirotani, K., Kondo, T., Inoue, H., & Iwata, N. (2014) · Folia Pharmacologica Japonica · doi:10.1254/fpj.143.23 · Cited by 2
Utility of Human Stem Cells for Drug Discovery
Chintawar, S., Graf, M. R., & Cader, M. Z. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620136-00162 · Cited by 2
Choi, W.-Y., Hwang, J.-H., Lee, J.-Y., Cho, A., Lee, A., Jung, I., Cho, S., Kim, L. K., & Kim, Y.-J. (2020) · Genes · doi:10.3390/genes11101176 · Cited by 2
3D Alzheimer's disease in a dish: Implications for drug discovery
Quinti, L., Park, J., Brand, E., Tanzi, R. E., & Kim, D. Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00014-8 · Cited by 2
CDiP technology for reverse engineering of sporadic Alzheimer’s disease
Kondo, T., Yada, Y., Ikeuchi, T., & Inoue, H. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01047-8 · Cited by 2
Emerging Methods in Modeling Brain Development and Disease with Human Pluripotent Stem Cells
Allen, G. E., Dhanda, A. S., & Julian, L. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2409-8_20 · Cited by 2
Stem Cell-based Therapy for Neurodegenerative Diseases
Takahashi, J. B. (2016) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.25.985 · Cited by 2
[IPS an ethical paradigm for biomedical research].
Antonio, J. (2013) · PubMed · Cited by 2
Ojeda, A. V., Awabdeh, D., Brewster, B., Rockne, R. C., O’Meally, D., Yin, H. H., Carlesso, N., Brown, C. E., Gutova, M., & Barish, M. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.12.637976 · Cited by 2
Amyloid β (Aβ) ELISA of Human iPSC-Derived Neuronal Cultures
Watanabe, H., Murakami, R., & Okano, H. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_407 · Cited by 1
Promising Prospects for Human Cerebral Organoids to Advance Alzheimer's Disease Research
López, V., Rosca, A., Liste, I., Mateos-Martínez, P., Coronel, R., González-Sastre, R., Martín-Benito, S., & López, V. (2023) · Progress in Neurobiology · doi:10.60124/j.pneuro.2023.20.05 · Cited by 1
Cho, J., Bae, S., Jeon, J., Transfeld, J. L., Lee, C., Nott, A., Gao, F., & Seo, J. (2025) · iScience · doi:10.1016/j.isci.2025.112446 · Cited by 1
Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region
Ondrejčák, T., Hu, N., Coode, E., Campbell, T., Corbett, G. T., Doykov, I., Mills, K. A., Walsh, D. M., Livesey, F. J., Rowan, M. J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02897-0 · Cited by 1
Dual Targeting of Tau Kinases and Autophagy by Abemaciclib Independent of CDK4/6 Inhibition
Han, J., Jeong, J., Lee, D., Jung, Y., Jin, Y., Jung, E. S., Kim, H. J., Kim, W. Y., Lee, C., & Mook‐Jung, I. (2026) · Advanced Science · doi:10.1002/advs.202513135 · Cited by 1
GluN2A-mediated currents and calcium signal in human iPSC-derived neurons
Escamilla, S., Avilés-Granados, C., Peralta, F. A., Paternain, A. V., Cortés‐Gómez, M., Zetterberg, H., de la Peña, E., Salas-Lucia, F., Sáez‐Valero, J., & Cuchillo‐Ibáñez, I. (2026) · Scientific Reports · doi:10.1038/s41598-026-38482-y · Cited by 1
Frisch, C., Baker, L., Srinivasan, G., Mintah, A. E., Leyasi, S., Pedroza, M., Galyon, B., & Brafman, D. A. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1856154
Metadata
- Authors
- Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., Carson, C. T., Laurent, L. C., Marsala, M., Gage, F. H., Remes, A. M., Koo, E. H., & Goldstein, L. S. B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Scripps Research Institute (US)
- BD Biosciences (United States) (US)
- University of Oulu (FI)
- Corresponding author
- Goldstein, Lawrence S. B.
- ORCID
- Venue
- Nature
- Published
- 2012-01-25
- Volume
- 482
- Issue
- 7384
- Pages
- 216-220
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3338985
- OpenAlex
- W2088714934
- Cited by
- 1,253
- References
- 37
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 73 · 2023: 61 · 2022: 100 · 2021: 73 · 2020: 105 · 2019: 86 · 2018: 87 · 2017: 76 · 2016: 108 · 2015: 105 · 2014: 106 · 2013: 95 · 2012: 74
- FWCI
- 81.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- (No Title)
- Funders
- Howard Hughes Medical Institute
- National Institute on Aging (P50AG005131)
- National Institute of General Medical Sciences (T32GM008666)
- National Institute of Neurological Disorders and Stroke (P30NS047101, RC1NS068705)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD001259)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, induced pluripotent stem cells, familial Alzheimer's disease, sporadic Alzheimer's disease, amyloid-beta secretion, gamma-secretase inhibitors, beta-secretase inhibitors, phosphorylated tau, glycogen synthase kinase-3β, APP proteolytic processing, iPSC-derived neurons, patient-derived fibroblasts
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Astrocytes, Cells, Cultured, Enzyme Activation, Female, Fibroblasts, Humans, Male, Middle Aged, Models, Biological, Neurons, Peptide Fragments, Phosphoproteins, Phosphorylation, Protease Inhibitors, Endosomes, Biomarkers, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Synapsins, tau Proteins, Coculture Techniques, Glycogen Synthase Kinase 3, Amyloid Precursor Protein Secretases, Induced Pluripotent Stem Cells, Proteolysis, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
